Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BERGMAN

Showing results (711-720 of 784) with videos related to

Pageof 79
Sort By:
European Urology|August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term SurvivorsKarim Fizazi, Charles G Drake, Tomasz M Beer, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 2, 2020
Multicenter study on the diagnostic performance of multiframe volumetric laser endomicroscopy targets for Barrett's esophagus neoplasia with histopathology correlationM R Struyvenberg, A J de Groof, A Kahn, et al.
Gastroenterology|August 1, 2025
GastroNet-5M: A Multicenter Dataset for Developing Foundation Models in Gastrointestinal EndoscopyMartijn R Jong, Tim G W Boers, Kiki N Fockens, et al.
Nature Communications|November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialJeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
The Journal of Clinical Investigation|November 19, 2024
Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in miceKatherine L Morel, Beatriz Germán, Anis A Hamid, et al.
Genome Biology|May 12, 2021
Functional mapping of androgen receptor enhancer activityChia-Chi Flora Huang, Shreyas Lingadahalli, Tunc Morova, et al.
Future Oncology (London, England)|May 30, 2020
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancerMalou Cp Kuppen, Hans M Westgeest, Maarten J van der Doelen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2022
Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early NeoplasiaSanne N van Munster, Esther Nieuwenhuis, Raf Bisschops, et al.
Endoscopy|January 30, 2025
Impact of standard enhancement settings of endoscopy systems on performance of endoscopic artificial intelligence systemsMartijn R Jong, Carolus H J Kusters, Querijn N E van Bokhorst, et al.
Clinical Genitourinary Cancer|March 13, 2025
Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Dianne Bosch, Kim J M van der Velden, Tom Belleman, et al.
Pageof 79

Showing results (711-720 of 784) with videos related to

Sort By:
Pageof 79
European Urology|August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term SurvivorsKarim Fizazi, Charles G Drake, Tomasz M Beer, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 2, 2020
Multicenter study on the diagnostic performance of multiframe volumetric laser endomicroscopy targets for Barrett's esophagus neoplasia with histopathology correlationM R Struyvenberg, A J de Groof, A Kahn, et al.
Gastroenterology|August 1, 2025
GastroNet-5M: A Multicenter Dataset for Developing Foundation Models in Gastrointestinal EndoscopyMartijn R Jong, Tim G W Boers, Kiki N Fockens, et al.
Nature Communications|November 30, 2022
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialJeroen Kneppers, Tesa M Severson, Joseph C Siefert, et al.
The Journal of Clinical Investigation|November 19, 2024
Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in miceKatherine L Morel, Beatriz Germán, Anis A Hamid, et al.
Genome Biology|May 12, 2021
Functional mapping of androgen receptor enhancer activityChia-Chi Flora Huang, Shreyas Lingadahalli, Tunc Morova, et al.
Future Oncology (London, England)|May 30, 2020
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancerMalou Cp Kuppen, Hans M Westgeest, Maarten J van der Doelen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2022
Development and External Validation of a Model to Predict Complex Treatment After Radiofrequency Ablation for Barrett's Esophagus With Early NeoplasiaSanne N van Munster, Esther Nieuwenhuis, Raf Bisschops, et al.
Endoscopy|January 30, 2025
Impact of standard enhancement settings of endoscopy systems on performance of endoscopic artificial intelligence systemsMartijn R Jong, Carolus H J Kusters, Querijn N E van Bokhorst, et al.
Clinical Genitourinary Cancer|March 13, 2025
Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC)Dianne Bosch, Kim J M van der Velden, Tom Belleman, et al.
Pageof 79